V114 Pneumococcal Vaccine Demonstrates Acceptable Safety Profile For Infants, Study Suggests

HealthDay (6/13, Gotkine) reports, “VAXNEUVANCE (V114), the 15-valent pneumococcal conjugate vaccine containing the 13 serotypes in Prevnar 13 plus serotypes 22F and 33F, is well-tolerated and safe for infants, according to a study.” The findings were pub...